RYAN SUNG-EUN CHO
Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology CEDAR PARK, TX NPI 1699096180
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology TX Celgene Corporation All categories
General Payments — all program years on this page
$4,645.50
- Category: General Payments
- Program years: PY2019–2024
- Record count: 144
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,864.52 across 80 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,836.95 | 78 |
| Education | $27.57 | 2 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Celgene Corporation | $218.55 | 9 |
| BOSTON SCIENTIFIC CORPORATION | $218.13 | 5 |
| ABBVIE INC. | $161.91 | 7 |
| Janssen Biotech, Inc. | $156.98 | 12 |
| QOL Medical, LLC | $144.50 | 5 |
| Lilly USA, LLC | $129.65 | 5 |
| GENZYME CORPORATION | $118.43 | 5 |
| Regeneron Healthcare Solutions, Inc. | $107.20 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $88.87 | 4 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $86.06 | 5 |
| PFIZER INC. | $73.15 | 4 |
| Organon LLC | $59.95 | 3 |
| Celltrion USA Inc. | $46.80 | 3 |
| Fresenius Kabi USA, LLC | $43.63 | 2 |
| Madrigal Pharmaceuticals | $41.81 | 2 |
| Astellas Pharma US Inc | $32.84 | 1 |
| Merck Sharp & Dohme Corporation | $32.63 | 1 |
| Medtronic, Inc. | $30.57 | 1 |
| AIMMUNE THERAPEUTICS, INC. | $26.86 | 1 |
| Gilead Sciences, Inc. | $23.21 | 1 |
| Enterra Medical, Inc. | $22.79 | 1 |
By program year
Records — PY2024 (80)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.